#de novo molecular design

Discover 2 curated intelligence briefings related to this specific topic.

Sequence-to-Function Modeling Ends the Trial-and-Error Era of Gene Delivery
Technology & Innovation

Sequence-to-Function Modeling Ends the Trial-and-Error Era of Gene Delivery

High-density guide on implementing context-aware models and genome-scale atlases to eliminate the stochasticity of in-vivo gene delivery and CAR T pharmaceuticalization.

Read Analysis
Generative Chemistry Just Broke the Lab Bottleneck
Technology & Innovation

Generative Chemistry Just Broke the Lab Bottleneck

The surge in de novo molecular design, powered by $400M infusions and quantum-enhanced AI, has created a critical divergence: software is designing drugs and polymers at a velocity that physical labs and manufacturing plants cannot match.

Read Analysis